Development of a cocktail of recombinant-expressed human rabies virus-neutralizing monoclonal antibodies for postexposure prophylaxis of rabies.
about
Novel rabies virus-neutralizing epitope recognized by human monoclonal antibody: fine mapping and escape mutant analysis.Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants.Post-exposure Treatment with Anti-rabies VHH and Vaccine Significantly Improves Protection of Mice from Lethal Rabies InfectionProtective efficacy of passive immunization with monoclonal antibodies in animal models of H5N1 highly pathogenic avian influenza virus infectionGenetically delivered antibody protects against West Nile virusCharacterization of a human antibody fragment Fab and its calcium phosphate nanoparticles that inhibit rabies virus infection with vaccineDevelopment of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans.Engineering, expression in transgenic plants and characterisation of E559, a rabies virus-neutralising monoclonal antibody.Quantifying antigenic relationships among the lyssaviruses.Generation and characterization of neutralizing human recombinant antibodies against antigenic site II of rabies virus glycoprotein.Protective effect of different anti-rabies virus VHH constructs against rabies disease in mice.Met-CCL5 represents an immunotherapy strategy to ameliorate rabies virus infection.Postexposure treatment with the live-attenuated rabies virus (RV) vaccine TriGAS triggers the clearance of wild-type RV from the Central Nervous System (CNS) through the rapid induction of genes relevant to adaptive immunity in CNS tissues.Development of recombinant human polyclonal antibodies for the treatment of complex human diseases.Production, characterization, and antigen specificity of recombinant 62-71-3, a candidate monoclonal antibody for rabies prophylaxis in humans.Lyssaviruses.Generation and characterization of the human neutralizing antibody fragment Fab091 against rabies virus.mRNA mediates passive vaccination against infectious agents, toxins, and tumors.Preparation and diagnostic use of a novel recombinant single-chain antibody against rabies virus glycoprotein.Development and characterization of novel chimeric monoclonal antibodies for broad spectrum neutralization of rabies virus.Profiling highly conserved microrna expression in recombinant IgG-producing and parental Chinese hamster ovary cells.Problems in using statistical analysis of replacement and silent mutations in antibody genes for determining antigen-driven affinity selection.In Vivo Efficacy of a Cocktail of Human Monoclonal Antibodies (CL184) Against Diverse North American Bat Rabies Virus Variants
P2860
Q24520604-BAFF8EF4-A251-4784-905D-4653883D46CBQ24531953-79C5DF5E-AB92-48DD-9E6C-709AE87F9391Q27303580-707F663B-7111-42B9-815C-FA8EC63B8878Q27324824-83360123-2106-48E0-AB7B-3ED103A463E7Q27485481-1461E050-4BAC-44BF-9F85-73771F48F84FQ28740385-72820D41-E260-4AD5-903B-58656950E1D9Q33514828-9ED265D9-BFA4-4B91-828C-6CA3462EB187Q33816066-07AD472C-F809-408E-9D0B-3E077C658156Q34296085-EB12E514-939B-436A-A756-EDA315E99274Q34296691-014192B4-C0D1-4954-B757-26B0589E9F96Q34408085-7D66B7FF-BB34-41FE-B63B-8224FC034490Q34571301-7FF907F5-6263-43E9-B71B-7F75EC7484EBQ35826226-992B3A18-873B-4DA2-813F-3C5F6562AB80Q36569741-5FF8057D-B6A5-4152-9E29-70D47779058CQ36788708-B849CB48-E8E1-4E43-80FC-E2BF86C022F4Q37011499-C66A5183-4C59-41DA-9DD3-CD32982F46ADQ37728833-52ACD93A-060F-4168-AAA4-49D1D9D51BACQ40088616-D66D8A2B-FDA3-4D9A-9CF8-01D557F960AEQ42240366-477A57E5-FAF1-4D26-BAFF-3ECDAB2D94E7Q42680315-A9CBD756-D6C6-4A96-ADA7-FF57EBEC7A21Q51767113-668CC8EA-614C-482B-A064-8CD29FB41D42Q52992155-EED8C146-43C8-42D8-B06B-6347F3FF3948Q56996860-2A48280A-7E2E-4DE3-96D7-6F0C6FDFF21D
P2860
Development of a cocktail of recombinant-expressed human rabies virus-neutralizing monoclonal antibodies for postexposure prophylaxis of rabies.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Development of a cocktail of r ...... xposure prophylaxis of rabies.
@en
type
label
Development of a cocktail of r ...... xposure prophylaxis of rabies.
@en
prefLabel
Development of a cocktail of r ...... xposure prophylaxis of rabies.
@en
P2093
P356
P1476
Development of a cocktail of r ...... xposure prophylaxis of rabies.
@en
P2093
Bernhard Dietzschold
Cathleen A Hanlon
D Craig Hooper
Mikhail Prosniak
Milosz Faber
P356
10.1086/375247
P407
P577
2003-06-23T00:00:00Z